Clinical Trials Browser

Phase 1 × Malignant Solid Tumors × tislelizumab × Clear all

NCT05441046 2022-07-06

Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Malignant Solid Tumors